CD34+ -enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back-Reference-Cited by-同舟云学术

CD34+ -enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back

Published:2002-08-29 Issue:4 Volume:118 Page:1095-1103
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Bornhäuser Martin,Platzbecker Uwe,Theuser Catrin,Hölig K.,Ehninger Gerhard

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03731.x/fullpdf

Reference45 articles.

1. Treatment of high-risk acute leukaemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype;Aversa;New England Journal of Medicine,1998

2. Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation;Bensinger;Journal of Clinical Apheresis,1990

3. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy;Bensinger;Blood,1996

4. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers;Bensinger;New England Journal of Medicine,2001

5. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukaemia;Bonini;Science,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Clinical Translation Considerations for the Next Wave of Gene Modified Hematopoietic Stem and Progenitor Cells Therapies;Expert Opinion on Biological Therapy;2022-07-22

2. Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases;Biology of Blood and Marrow Transplantation;2017-09

3. Evaluation of bone marrow mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of volumetric muscle loss injuries;Stem Cell Research & Therapy;2017-06-09

4. Ex vivo T-cell–depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy;Cytotherapy;2017-06

5. The road to purified hematopoietic stem cell transplants is paved with antibodies;Current Opinion in Immunology;2012-10